Position in NEO
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,123
New position
Shares Held
77
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#243
of 265 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Aspect Partners, LLC holds $182,838 across 9 Diagnostics & Research names. NEO ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
302 | $151,409 | |
| 2 | DHR |
Danaher Corp /De/
|
64 | $12,190 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
31 | $5,988 | |
| 4 | WAT |
Waters Corp /De/
|
13 | $4,875 | |
| 5 | DGX |
Quest Diagnostics Inc
|
14 | $2,966 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
4 | $2,105 | |
| 7 | NEO |
Neogenomics Inc
This page
|
77 | $1,123 | |
| 8 | LH |
Labcorp Holdings Inc.
|
4 | $1,120 |
All Filings in NEO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,123 | 77 | Shares | Sole | 2026-07-16 | |
| No filing history on record for this holder in this stock. | ||||||